Безопасен ли sophora flavescens root extract при беременности?
No harmonised CLP classification (ECHA Annex VI) for Sophora flavescens root extract and no CIR or SCCS safety assessment was identified. Peer‑reviewed literature describes pharmacologically active alkaloids (matrine/oxymatrine) in the root, but reproductive toxicity in humans or clear animal developmental toxicity from topical exposure was not found in available sources; therefore default hazard/mechanism scores are 0. Low but measurable exposure is assigned given known small‑molecule alkaloid constituents that can be systemically bioavailable in other uses (PubMed, PubChem).
Pregnancy-safe products containing sophora flavescens root extract










Related ingredients
Frequently asked questions
- Безопасен ли sophora flavescens root extract при беременности?
- No harmonised CLP classification (ECHA Annex VI) for Sophora flavescens root extract and no CIR or SCCS safety assessment was identified. Peer‑reviewed literature describes pharmacologically active alkaloids (matrine/oxymatrine) in the root, but reproductive toxicity in humans or clear animal developmental toxicity from topical exposure was not found in available sources; therefore default hazard/mechanism scores are 0. Low but measurable exposure is assigned given known small‑molecule alkaloid constituents that can be systemically bioavailable in other uses (PubMed, PubChem).
- Безопасен ли sophora flavescens root extract при грудном вскармливании?
- Same rationale as pregnancy: no regulatory harmonised reproductive flags or authoritative cosmetic‑safety assessment (CIR/SCCS). Potential for low systemic absorption of alkaloid constituents exists but transfer into breastmilk from topical cosmetic use is not demonstrated in available sources.
- Безопасен ли sophora flavescens root extract для кожи малыша?
- No infant‑specific reproductive/toxicity data located and no harmonised classification. Because botanical extracts may contain small alkaloid constituents and infant skin has higher per‑kg absorption, exposure score is increased by +1 relative to adults (per protocol). No evidence was found that infant use causes developmental or reproductive harm.
- Как VeriMom оценивает sophora flavescens root extract?
- VeriMom оценивает sophora flavescens root extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы sophora flavescens root extract при беременности?
- См. наш список безопасных альтернатив sophora flavescens root extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.